Mutual Fund Details

UTI Healthcare Fund Direct-Growth

Name: UTI Healthcare Fund Direct-Growth
Brand: UTI Mutual Fund

Equity Pharma

NAV

₹326.0604

as on 03 Dec 2024, 11:18 PM

₹0.5702(0.18%)

Last Change

Scheme Ratings

Pharma

5Y Returns

rated by Value Research

Pharma

Rankings based on 5Y Returns | as on 18 Nov 2024

DSP Healthcare Fund Direct - Growth

32.98%

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

31.53%

Mirae Asset Healthcare Fund Direct - Growth

30.64%

SBI Healthcare Opportunities Fund Direct Plan-Growth

30.50%

UTI Healthcare Fund Direct-Growth

29.22%

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,79,735

₹1,85,462

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹85,463

Profit (absolute return)

85.46%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

3.79%

In the last 6 months

30.95%

In the last 1 year

47.11%

In the last 3 years

85.46%

In the last 5 years

262.14%

In the last 10 years

272.30%

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

UTI Healthcare Fund Direct-Growth

as of 31 Oct 2024, 05:30 AM

₹1,187.02 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 1% if redeemed within 30 days.

1.25%

Expense Ratio

Plan

Growth

1.41%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

Exit load of 1% if redeemed within 30 days.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Sector

Healthcare

97.43%

₹1,156.56 Cr

Insurance

1.04%

₹12.34 Cr

Others

1.53%

₹18.16 Cr

Sectors Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Sector

Healthcare

97.43%

₹1,156.56 Cr

Insurance

1.04%

₹12.34 Cr

Others

1.53%

₹18.16 Cr

Companies Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

11.34%

₹134.61 Cr

Cipla Ltd.

6.61%

₹78.46 Cr

Dr. Reddy's Laboratories Ltd.

5.66%

₹67.19 Cr

Ajanta Pharma Ltd.

5.29%

₹62.79 Cr

Apollo Hospitals Enterprise Ltd.

4.07%

₹48.31 Cr

Others

67.03%

₹795.66 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

11.34%

₹134.61 Cr

Cipla Ltd.

6.61%

₹78.46 Cr

Dr. Reddy's Laboratories Ltd.

5.66%

₹67.19 Cr

Ajanta Pharma Ltd.

5.29%

₹62.79 Cr

Apollo Hospitals Enterprise Ltd.

4.07%

₹48.31 Cr

Others

67.03%

₹795.66 Cr

View All

Funds in this Category

This fund's returns:

22.84%

Return Duration

3 Years

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

SBI Healthcare Opportunities Fund Direct Plan-Growth

DSP Healthcare Fund Direct - Growth

About UTI Healthcare Fund Direct-Growth

UTI Healthcare Fund Direct-Growth is a Equity mutual fund scheme from UTI Mutual Fund. This scheme was launched on Invalid date. It has an AUM of ₹1,187.02 Crores and the latest NAV decalared is ₹326.060 as on 04 Dec 2024 at 2:40 pm.

UTI Healthcare Fund Direct-Growth scheme return performance in last 1 year is 47.11%, in last 3 years is 85.46% and 583.28% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.